JBIO · Jade Biosciences, Inc.
$21.23
-1.32 (-5.85%)
At close · Aug 20
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.43B
Shares
63.60M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-13 | 1,608,346 | 894,969 | 2,503,315 | 45.1% |
| 2026-07-06 | 1,771,593 | 266,415 | 2,038,008 | 40.5% |
| 2026-06-29 | 1,416,440 | 420,087 | 1,836,527 | 45.0% |
| 2026-06-22 | 2,177,371 | 1,254,174 | 3,431,545 | 42.0% |
| 2026-06-15 | 1,511,376 | 1,822,376 | 3,333,752 | 40.9% |
| 2026-06-08 | 2,373,861 | 538,040 | 2,911,901 | 46.3% |
| 2026-06-01 | 3,549,235 | 1,174,794 | 4,724,029 | 45.6% |
| 2026-05-25 | 732,700 | 448,197 | 1,180,897 | 44.6% |
| 2026-05-18 | 682,297 | 766,918 | 1,449,215 | 54.8% |
| 2026-05-11 | 689,957 | 115,029 | 804,986 | 45.1% |
| 2026-05-04 | 1,095,718 | 234,127 | 1,329,845 | 52.1% |
| 2026-04-27 | 1,022,137 | 802,845 | 1,824,982 | 47.1% |
| 2026-04-20 | 1,441,171 | 1,004,099 | 2,445,270 | 59.9% |
| 2026-04-13 | 1,216,260 | 487,834 | 1,704,094 | 52.7% |
| 2026-04-06 | 1,810,300 | 714,835 | 2,525,135 | 68.5% |
| 2026-03-30 | 1,304,447 | 689,796 | 1,994,243 | 55.3% |
| 2026-03-23 | 346,110 | 98,540 | 444,650 | 31.1% |
| 2026-03-16 | 792,754 | 1,228,056 | 2,020,810 | 46.6% |
| 2026-03-09 | 754,130 | 306,592 | 1,060,722 | 46.9% |
| 2026-03-02 | 342,523 | 159,910 | 502,433 | 39.1% |
| 2026-02-23 | 403,058 | 320,950 | 724,008 | 52.1% |
| 2026-02-16 | 195,476 | 133,442 | 328,918 | 43.1% |
| 2026-02-09 | 306,288 | 54,109 | 360,397 | 32.2% |
| 2026-02-02 | 358,192 | 69,524 | 427,716 | 36.2% |
| 2026-01-26 | 249,983 | 427,888 | 677,871 | 54.5% |
| 2026-01-19 | 253,356 | 158,954 | 412,310 | 38.5% |
| 2026-01-12 | 516,428 | 182,780 | 699,208 | 48.5% |
| 2026-01-05 | 454,149 | 175,244 | 629,393 | 35.3% |
| 2025-12-29 | 213,154 | 115,655 | 328,809 | 31.9% |
| 2025-12-22 | 289,004 | 76,276 | 365,280 | 39.8% |
| 2025-12-15 | 564,861 | 827,183 | 1,392,044 | 35.2% |
| 2025-12-08 | 513,543 | 111,154 | 624,697 | 38.4% |
| 2025-12-01 | 377,546 | 270,520 | 648,066 | 44.6% |
| 2025-11-24 | 203,809 | 45,094 | 248,903 | 34.7% |
| 2025-11-17 | 331,317 | 212,112 | 543,429 | 40.0% |
| 2025-11-10 | 390,379 | 81,791 | 472,170 | 42.1% |
| 2025-11-03 | 142,132 | 506,903 | 649,035 | 57.9% |
| 2025-10-27 | 250,399 | 373,115 | 623,514 | 56.9% |
| 2025-10-20 | 236,008 | 88,795 | 324,803 | 36.3% |
| 2025-10-13 | 296,926 | 99,009 | 395,935 | 46.1% |
| 2025-10-06 | 472,796 | 373,889 | 846,685 | 50.7% |
| 2025-09-29 | 42,310 | 57,745 | 100,055 | 38.5% |
| 2025-09-22 | 60,455 | 59,691 | 120,146 | 37.1% |
| 2025-09-15 | 93,266 | 74,317 | 167,583 | 34.0% |
| 2025-09-08 | 38,708 | 33,857 | 72,565 | 34.5% |
| 2025-09-01 | 48,999 | 27,632 | 76,631 | 32.9% |
| 2025-08-25 | 87,242 | 51,207 | 138,449 | 38.6% |
Showing 1–47 of 47 weeks
Key facts
CIK
1798749
CUSIP
008064206
13F (30d)
148 filings
147 filers
Visit website
Investor relations